Drug intelligence / Profile preview

rho(d) immune globulin intravenous

Development stage
Approved
Lead developer
Ortho Clinical Diagnostics
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous, Intramuscular
01

Overview

Rho(D) immune globulin intravenous is a sterile solution of IgG antibodies to the Rh(D) antigen derived from human plasma. It is administered intravenously or intramuscularly and used primarily for two indications: - Prevention of Rh isoimmunization in Rh-negative individuals exposed to Rh-positive red blood cells (such as during pregnancy with an Rh-incompatible fetus or after transfusion with incompatible blood). - Treatment of immune thrombocytopenic purpura (ITP) in non-splenectomized patients who are Rho(D)-positive. The mechanism involves antibody-mediated immunosuppression by binding to and promoting clearance of Rho(D)-positive red blood cells before the recipient's immune system can mount an alloimmune response. In ITP, it increases platelet counts by inhibiting autoantibody-mediated platelet clearance through Fc receptor blockade on macrophages[2][3][5][7].

Brand names
BayRho-DHyperRHO S/DMicRhogam Ultra-FilteredRhoGAM Ultra-Filtered PlusRhophylacWinRho SDF
Other names
intravenous rho immune globulinrh0 d immune globulin intravenous humanrh-0 d immune globulin intravenous humanrh 0 d immune globulin intravenous humanrh0 d immune globulin ivrh-0 d immune globulin ivrh 0 d immune globulin iv
02

Targets

FCGR3A (Low affinity immunoglobulin gamma Fc region receptor III-A)

Beyond the preview

Go deeper on rho(d) immune globulin intravenous.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rho(d) immune globulin intravenous.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call